Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Regulatory
  • FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight
  • Regulatory

FDA Launches One-Day Inspectional Assessments to Strengthen and Expand Oversight

FDA

FDA announced that it is piloting one-day inspectional assessments, as part of a broader initiative to make its inspectional resources more targeted and efficient.

Read full story

pharminent May 6, 2026 (Last updated: May 6, 2026)

FDA

FDA announced that it is piloting one-day inspectional assessments, as part of a broader initiative to make its inspectional resources more targeted and efficient.

Read full story

Post navigation

Previous: Novo’s Wegovy pill reaches 1M patients, shattering expectations with $355M in sales
Next: Lilly inflates US facility investment spending by $4.5bn

Related Stories

  • Regulatory

Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion

pharminent September 10, 2026
  • Regulatory

HHS appoints permanent FDA CBER, CDER heads

pharminent September 10, 2026
  • Regulatory

FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer

pharminent September 7, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.